[Hearing loss resulting from purulent meningitis in the light of adjuvant dexamethasone therapy].
Results of objective audiometry of 109 infants and children after purulent meningitis are presented. Among them 17 patients got dexamethasone as a supportive therapy. There was no statistically significant difference in hearing loss between the dexamethasone-treated and the control group. (41 vs 43% sensorineural hearing loss respectively). Authors do not contraindicate the dexamethasone therapy in purulent meningitis because of its harmlessness and useful effect to the course of the disease but further investigations are needed for avoidance of hearing loss following meningitis.
Katona
G
G
Fül-Orr-Gége és Bronchologiai Osztály, Heim Pál Gyermekkórház-Rendelöintézet, Budapest.
Farkas
Z
Z
Hirschberg
J
J
Hajdi
G
G
Nyerges
G
G
D017024:Chemotherapy, Adjuvant; D002675:Child, Preschool; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005665:Furosemide / Q000008:administration & dosage / Q000627:therapeutic use; D006319:Hearing Loss, Sensorineural / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D008297:Male; D008583:Meningitis, Haemophilus / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology
D005665:Furosemide; D003907:Dexamethasone